LGALS1, for instance, has been implicated in several hallmark features of glioblastoma pathogenesis, including resistance to chemoradiotherapy, induction of neo-angiogenesis, and suppression of anti-tumour immune responses [20]. The gene discussed is LGALS1; the disease is glioblastoma.